Viewing Study NCT05502692


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2026-02-22 @ 12:23 PM
Study NCT ID: NCT05502692
Status: COMPLETED
Last Update Posted: 2023-05-24
First Post: 2022-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CHARACTERISE - A Cross-sectional, Observational Study to Characterise the Transition to Dolutegravir-based Regimens in South Africa in Terms of the Emergence of Obesity, Viral Re-suppression and Integration Into Routine Programme Care
Sponsor: University of Witwatersrand, South Africa
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: EZ-FV-030
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View